Evaluation of 5-year Survival and Clinical Outcomes in Patients Undergoing Total Knee Arthroplasty With a Polyethylene Tibial Component
ALLPOLY-TKA
1 other identifier
interventional
78
1 country
1
Brief Summary
Total knee arthroplasty (TKA) is one of the most successful procedures in orthopedic surgery for treating advanced knee osteoarthritis, providing pain relief, functional recovery, and improved quality of life. Advances in implant design and materials have further enhanced joint kinematics and patient satisfaction. An aging population has increased the number of elderly patients with comorbidities, potentially affecting surgical outcomes and implant longevity. Polyethylene has long been used in knee prostheses; early all-polyethylene tibial components were abandoned due to high wear and failure rates, in favor of metal-backed designs, which became the gold standard. Recently, highly cross-linked ultra-high-molecular-weight polyethylene (UHMWPE) has renewed interest in all-polyethylene tibial components, although their use remains limited. These implants offer potential advantages, including elimination of locking mechanism failures, reduced backside wear, lower costs, and possibly better load distribution. Evidence from registries, systematic reviews, and meta-analyses shows that 15-year survival of all-polyethylene tibial components is comparable or even superior to metal-backed designs, with no significant differences in clinical-functional outcomes. Additionally, all-poly components are significantly less expensive. Given these findings, increasing their use and evaluating outcomes in Italy is warranted. The aim of the present study is to assess implant survival of the Link Symphoknee prosthesis with an all-polyethylene tibial component, along with clinical-functional outcomes and post-discharge readmission rates in patients treated at the Rizzoli Orthopaedic Institute.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2026
CompletedFirst Posted
Study publicly available on registry
April 22, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2032
April 22, 2026
April 1, 2026
6.4 years
April 15, 2026
April 15, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Implant failure
It is defined as revision of the prosthesis for any reason-septic, aseptic, or traumatic.
Up to 5 years post-surgery
Secondary Outcomes (5)
Knee injury and Osteoarthritis Outcome Score (KOOS)
Up to 5 years post-surgery
Forgotten Joint Score (FJS)
Up to 5 years post-surgery
Visual Analog Scale (VAS) pain
Up to 5 years post-surgery
VAS Satisfaction
Up to 5 years post-surgery
Hip-Knee-Ankle angle (HKA)
Up to 5 years post-surgery
Study Arms (1)
TKA
EXPERIMENTALImplantation of the Link Symphoknee prosthesis with an all-polyethylene tibial component.
Interventions
Implantation of the Link Symphoknee prosthesis with an all-polyethylene tibial component
Eligibility Criteria
You may qualify if:
- Male and female subjects aged ≥50 and ≤85 years who are candidates for primary cemented total knee arthroplasty based on physical examination and medical history, including a diagnosis of severe knee pain and disability due to at least one of the following conditions:
- Primary or secondary osteoarthritis
- Collagen disorders and/or avascular necrosis of the femoral condyle
- Moderate valgus, varus, or flexion deformities (Hip-Knee-Ankle angle within ±15°).
- Patients who provide consent and are able to complete the scheduled study procedures and follow-up assessments.
- Patients who sign the informed consent approved by the Ethics Committee.
You may not qualify if:
- Patients under 50 years of age and over 85 years of age;
- Diagnosis of rheumatoid arthritis;
- Patients with a contralateral joint prosthesis on the same side;
- Coronal plane deformity with a Hip-Knee-Ankle (HKA) angle greater than 15 degrees in varus or valgus.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Rizzoli Orthopedic Institute
Bologna, 40136, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor Medicine and Surgery, University of Bologna
Study Record Dates
First Submitted
April 15, 2026
First Posted
April 22, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
October 1, 2032
Study Completion (Estimated)
October 1, 2032
Last Updated
April 22, 2026
Record last verified: 2026-04